Microfluidic devices for in vitro studies on liver drug metabolism and toxicity
The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Abstract
Microfluidic technologies enable the fabrication of advanced in vitro systems incorporating liver tissue or cells to perform metabolism and toxicity studies for drugs and other xenobiotics. The use of microfluidics provides the possibility to utilize a flow of medium, thereby creating a well-controlled microenvironment. The general goals of most in vitro systems in drug research are to optimally mimic the in vivo situation, and to minimize the number of animals required for preclinical studies. Moreover, they may contribute to a reduced attrition rate of drugs at a late stage of the drug development process; this is especially true if human tissue or cells are used. A number of factors are important in achieving good in vivo predictability in microfluidic systems, of which the biological system itself (cells or tissue) and the incubation conditions are the most important. The last couple of years have seen various microfluidic-based in vitro systems being developed to incorporate many different cells and/or tissues. In this review, microfluidics-based in vitro systems realized to study liver metabolism and toxicity are summarized and discussed with respect to their applications, advantages, and limitations. The biological basis of these systems is evaluated, and incubation conditions considered. Precise control of the cell or tissue microenvironment is a key advantage of using microfluidic technologies, and the benefits of exposing the cells to medium flow are demonstrated. Special attention is also paid to the incorporation of multiple cell types or tissues into a microfluidic device for the investigation of interorgan interactions, which are difficult if not impossible to study in conventional systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current drug development process suffers from a high failure rate during clinical trials, which is partly due to inadequacy of animal models to accurately predict the toxic side-effects of drugs in humans [1,2].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [1]
Citations
Cites
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Capturing complex 3D tissue physiology in vitro
Griffith, L. G., & Swartz, M. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1858 · Cited by 2,290
Laser, D. J., & Santiago, J. G. (2004) · Journal of Micromechanics and Microengineering · doi:10.1088/0960-1317/14/6/r01 · Cited by 1,848
Lab-on-a-chip: microfluidics in drug discovery
Dittrich, P. S., & Manz, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1985 · Cited by 1,844
Bile acids: regulation of synthesis
Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,515
Microscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219
PDMS absorption of small molecules and consequences in microfluidic applications
Toepke, M. W., & Beebe, D. J. (2006) · Lab on a Chip · doi:10.1039/b612140c · Cited by 1,190
Generation of Solution and Surface Gradients Using Microfluidic Systems
Jeon, N. L., Dertinger, S. K. W., Chiu, D. T., Choi, I. S., Stroock, A. D., & Whitesides, G. M. (2000) · Langmuir · doi:10.1021/la000600b · Cited by 963
Generation of Gradients Having Complex Shapes Using Microfluidic Networks
Dertinger, S. K. W., Chiu, D. T., Jeon, N. L., & Whitesides, G. M. (2001) · Analytical Chemistry · doi:10.1021/ac001132d · Cited by 839
Wilkening, S., Stahl, F., & Bader, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1035 · Cited by 794
Research works printed but not linked: 3
- Nyberg, 1994, Ann. Surg., 220, 59
- LeCluyse, 2005, Methods Mol. Biol., 290, 207
- Neufeld, 1997, Methods Mol. Biol., 75, 145
Cited by
Items 101–117 of 117
Microfluidics Technology for Nanoparticles and Equipment
Kumar, S. L. (2021) · Springer eBooks · doi:10.1007/978-3-030-50703-9_4 · Cited by 4
Kovar, L., Wien, L., Selzer, D., Kohl, Y., Bals, R., & Lehr, T. (2022) · Pharmaceuticals · doi:10.3390/ph15020250 · Cited by 3
Microchip Technology in Metabolomics
Sikanen, T. M. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849737272-00138 · Cited by 3
One-layer microfluidic device for hydrodynamic 3D self-flow-focusing operating in low flow speed
Daghighi, Y., Gnyawali, V., Strohm, E. M., Tsai, S. S. H., & Kolios, M. C. (2016) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2212892 · Cited by 2
Microfluidic devices for stem cell analysis
Kang, D., Lu, J., Zhang, W., Chang, E., Eckert, M. A., Ali, M. M., Zhao, W., & Li, X. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819971-8.00013-5 · Cited by 2
Metabolism Studies In Vitro and In Vivo: An Editorial Update
Marker, A., Riedel, J., Dudda, A., & Kuerzel, G. U. (2024) · Springer eBooks · doi:10.1007/978-3-031-35529-5_109 · Cited by 1
Application of Microfluidics in Stem Cell Culture
Sugiura, S., Nakazawa, K., Kanamori, T., & Ohnuma, K. (2016) · InTech eBooks · doi:10.5772/64714 · Cited by 2
Metabolic Characterization of Cell Systems Used in In Vitro Toxicology Testing
Garcia‐Canton, C., & Minet, E. (2016) · Wiley eBooks · doi:10.1002/9780470921920.edm142 · Cited by 2
Increasing the versatility of an ex vivo model in nanosafety studies and fibrosis
Bartucci, R. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.119127385 · Cited by 1
Microfluidics nucleic acid testing for point-of-care liver assessment
Lim, G. S. (2016) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/68640
Szuplewska, A., Chudy, M., & Brzózka, Z. (2017) · Springer eBooks · doi:10.1007/978-3-319-70685-6_4 · Cited by 1
Cui, J., Wang, H., Shi, Q., Li, J., Zheng, Z., Sun, T., Huang, Q., & Fukuda, T. (2018) · International Conference on Manipulation, Automation and Robotics at Small Scales (MARSS) · doi:10.1109/marss.2018.8481232
"Microfluidic vessels-on-chips for vascular disease modelling"
Middelkamp, H. H. T. (2023) · doi:10.3990/1.9789036557245
Metabolism Studies In Vitro and In Vivo: An Editorial Update
Marker, A., Riedel, J., Dudda, A., & Kuerzel, G. U. (2024) · Springer eBooks · doi:10.1007/978-3-030-73317-9_109-1
Bioprinting 3D : uma alternativa à experimentação animal em farmacotoxicologia
Almeida, J. M. D. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Microfluidics in drug development
Rahmanian, M., Naghib, S. M., Davodabadi, F., & Ghanbari, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45538-4.00006-6
Metadata
- Authors
- van Midwoud, P. M., Verpoorte, E., & Groothuis, G. M. M.
- Affiliations
- University of Groningen (NL)
- Corresponding author
- Groothuis, Geny M. M.
- Venue
- Integrative Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011
- Volume
- 3
- Issue
- 5
- Pages
- 509
- ISSN
- 1757-9694 (ISSN-L)
- 1757-9708
- OpenAlex
- W2084745931
- Cited by
- 115
- References
- 123
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 6 · 2023: 4 · 2022: 7 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 14 · 2017: 5 · 2016: 17 · 2015: 9 · 2014: 10 · 2013: 17 · 2012: 6
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Integrative Biology (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- microfluidics, liver drug metabolism, drug toxicity, in vitro liver models, human liver cells, xenobiotic metabolism, microenvironment control, animal use reduction, drug attrition
- MeSH terms
- Animals, Biological Assay, Equipment Design, Humans, Liver, Pharmacokinetics, Flow Injection Analysis, Toxicity Tests, Cell Culture Techniques, Microfluidic Analytical Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.